Shi Qiong, Yan Hong
Department of Ophthalmology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, Shaanxi Province, China.
Int J Ophthalmol. 2010;3(3):211-5. doi: 10.3980/j.issn.2222-3959.2010.03.07. Epub 2010 Sep 18.
To investigate the effect of carnosine (Car), aspirin (Asp) and a combination of Car and Asp eye drops on the change of the thiol contents from glutathione (GSH) and protein in the corneas of the diabetic rats.
All the animals were randomly divided into five groups. The normal control group received injections of vehicle only. Diabetes was induced by injection of streptozotocin (STZ) in the Sprague-Dawley (SD) rats. The untreated group rats received only the vehicle solution (the placebo). One treated group rats were treated by instillation of one drop of 10g/L Car eye drops, another were treated by 0.5g/L Asp eye drops and the last group were treated alternately by Car 10g/L and Asp 0.5g/L eye drops for a period of 8 weeks. At the end of 8 weeks, the animals were killed and the thiols contents in the corneas were investigated.
About 15.6% of the rats (blood glucose measured <14mmol/L) were rejected. In the corneas, the levels of thiols were declined in the untreated, Asp-treated group and combination-treated group, but they went up in Car-treated group. The levels of thiols in the Car-treated groups were much higher than that in the untreated group, and there was statistically significant difference between them (P<0.05).
The results indicated that diabetes decreases the levels of thiols (from GSH and proteins) in the cornea. The Car eye drops in our study may protect the cornea against the oxidative damage caused by diabetes. And the combination eye drops also may have a certain protection for the diabetic corneas.
研究肌肽(Car)、阿司匹林(Asp)及肌肽与阿司匹林联合滴眼液对糖尿病大鼠角膜中谷胱甘肽(GSH)和蛋白质中硫醇含量变化的影响。
将所有动物随机分为五组。正常对照组仅注射赋形剂。通过向斯普拉格-道利(SD)大鼠注射链脲佐菌素(STZ)诱导糖尿病。未治疗组大鼠仅接受赋形剂溶液(安慰剂)。一组治疗组大鼠滴注10g/L肌肽滴眼液,另一组用0.5g/L阿司匹林滴眼液治疗,最后一组交替使用10g/L肌肽和0.5g/L阿司匹林滴眼液治疗8周。8周结束时,处死动物并检测角膜中的硫醇含量。
约15.6%的大鼠(血糖测量值<14mmol/L)被排除。在角膜中,未治疗组、阿司匹林治疗组和联合治疗组的硫醇水平下降,但肌肽治疗组的硫醇水平上升。肌肽治疗组的硫醇水平远高于未治疗组,且二者之间存在统计学显著差异(P<0.05)。
结果表明糖尿病会降低角膜中硫醇(来自GSH和蛋白质)的水平。本研究中的肌肽滴眼液可能保护角膜免受糖尿病引起的氧化损伤。联合滴眼液对糖尿病角膜也可能有一定的保护作用。